<p dir="ltr">ICANN lacks the legitimacy to do anything in this regard. Its contracted parties can possibly do something such as verisign that has taken down a number of .com domains in collaboration with the US authorities on various occasions. The pharma guys are just trying to get some limelight by calling out to ICANN and trying to attempt a bit of harassing the domain community by going to WIPO that most of the times appears bewildered on IG or open access issues. The WIPO itself is yet to face the surges to emerge from the newGTLD process.</p>
<p dir="ltr">On the other hand counterfeit drugs of any sort should be countered but its the payment, postal, freight and delivery systems that require moderation and not just Internet.</p>
<p dir="ltr">Somebody must tell the pharma people that ICANN is not the Viagara of the Internet or the means to stop counterfeit trade of drugs, its just a .0000001% of the pharma industry's incapacity to keep its business clean and no business by far is clean!</p>
<p dir="ltr">Fouad Bajwa</p>
<div class="gmail_quote">On Aug 2, 2012 1:53 PM, "Riaz K Tayob" <<a href="mailto:riaz.tayob@gmail.com">riaz.tayob@gmail.com</a>> wrote:<br type="attribution"><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div bgcolor="#FFFFFF" text="#000000">
[After Global Pharma got WHO to do some work on this, then poor
countries realised that that this was an industry driven process,
they protested at WHO, and WHO only relented after getting a number
of thwacks... I guess ICANN will more amenable given its lack of
legitimacy and "can do" spirit...after all it was ICANN et al that
contributed to make domain names equivalent to trademarks... for
that there is no problem going to WIPO... an UN body... perhaps cos
there is money there... not to be crass of course... ]<br>
<h2> Global Pharma Calls On ICANN To Act Against
Online Counterfeits </h2>
<small>Published on 28 July 2012 @ 2:06 pm</small>
<p> <span><span style="display:inline-block;text-decoration:none"><span style="background-image:url("http://w.sharethis.com/images/facebook_counter.png")"> </span></span></span><span><span style="display:inline-block;text-decoration:none"><span style="background-image:url("http://w.sharethis.com/images/twitter_counter.png")"> </span></span></span><span><span style="display:inline-block;text-decoration:none"><span style="background-image:url("http://w.sharethis.com/images/email_counter.png")"> </span></span></span><span><span style="display:inline-block;text-decoration:none"><span style="background-image:url("http://w.sharethis.com/images/sharethis_counter2.png")"> </span></span></span>
<span><a href="http://www.ip-watch.org/2012/07/28/global-pharma-calls-on-icann-to-act-against-online-counterfeits/print/" title="Print This Post" rel="nofollow" target="_blank"><img src="cid:part1.07080000.00000603@gmail.com" alt="Print This
Post" title="Print This Post" style="border:0px"></a> <a href="http://www.ip-watch.org/2012/07/28/global-pharma-calls-on-icann-to-act-against-online-counterfeits/print/" title="Print This Post" rel="nofollow" target="_blank">Print This Post</a>
</span> </p>
<p>Intellectual Property Watch</p>
<div>
<p>The international pharmaceutical industry this week released a
policy statement targeting counterfeit medicines on the
internet. Among the recommendations was for the Internet
Corporation for Assigned Names and Numbers (ICANN) to join the
fight. </p>
<p>At the same time, the Center for Safe Internet Pharmacies was
launched in the United States, aimed at taking down illegal
internet pharmacies. More information about the CSIP is <a href="http://www.safemedsonline.org/" target="_blank">available here</a>. </p>
<p>Four research-based industry associations joined together to
issue a <a href="http://www.efpia.eu/position-papers/internet-sales-and-access-safe-medicines" target="_blank">joint
policy statement</a> on counterfeits online. </p>
<p>The groups are the International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA), Pharmaceutical
Research and Manufacturers of America (PhRMA), European
Federation of Pharmaceutical Industries and Associations
(EFPIA), and Japanese Pharmaceutical Manufacturers Association
(JPMA).</p>
<p>The groups showed support for governments, law enforcement, the
private sector and any others, working to stop counterfeit
medicines. </p>
<p>And they said, “We call upon [ICANN], which oversees the
assignment of generic top level domains and accredits domain
registrars, to take appropriate actions and ensure
accountability measures in order to protect Internet users from
illegitimate online sites that are engaged in the illicit sale
of prescription medicines.”</p>
<p>Up till now, ICANN has been explicitly considered to be a
technical oversight body with no policy authority. </p>
<p>But the stakes are high, industry says. “Everybody is at risk
of counterfeiting,” said Eduardo Pisani, IFPMA director general.
“Counterfeiting is a crime against patients and poses a public
health risk that can lead to treatment resistance, extended
illness, disability and even death.”</p>
</div>
</div>
<br>____________________________________________________________<br>
You received this message as a subscriber on the list:<br>
<a href="mailto:governance@lists.igcaucus.org">governance@lists.igcaucus.org</a><br>
To be removed from the list, visit:<br>
<a href="http://www.igcaucus.org/unsubscribing" target="_blank">http://www.igcaucus.org/unsubscribing</a><br>
<br>
For all other list information and functions, see:<br>
<a href="http://lists.igcaucus.org/info/governance" target="_blank">http://lists.igcaucus.org/info/governance</a><br>
To edit your profile and to find the IGC's charter, see:<br>
<a href="http://www.igcaucus.org/" target="_blank">http://www.igcaucus.org/</a><br>
<br>
Translate this email: <a href="http://translate.google.com/translate_t" target="_blank">http://translate.google.com/translate_t</a><br>
<br></blockquote></div>